Patents Assigned to Pangea Biotech, S.A.
  • Method for the detection of EGFR mutations in blood samples
    Patent number: 8637245
    Abstract: The present invention refers to the detection of EGFR mutations in a blood (serum/plasma) sample from a subject. The method comprises: (i) obtaining the DNA from said sample; (ii) amplifying the nucleic acid sequence corresponding to a specific region of the EGFR gene by means of PCR using a Protein-Nucleic Acid probe; 10 and (iii) detecting said mutation.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: January 28, 2014
    Assignee: Pangea Biotech, S.A.
    Inventors: Rafael Rosell Costa, Miguel Taron Roca